Showing results (71-80 of 184) with videos related to
Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Regulation of the CTL response by macrophage migration inhibitory factorR Abe, T Peng, J Sailors, et al.Kidney International|August 1, 1996
Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatmentT Soulis, M E Cooper, D Vranes, et al.Diabetes|January 1, 1995
A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryosA T Lee, A Plump, C DeSimone, et al.Medical Hypotheses|August 6, 2002
A role for peripheral blood fibrocytes in Lyme disease?D J Grab, M Salim, J Chesney, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Peripheral blood fibrocytes: differentiation pathway and migration to wound sitesR Abe, S C Donnelly, T Peng, et al.Atherosclerosis|April 17, 1998
Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbitS Panagiotopoulos, R C O'Brien, R Bucala, et al.The Journal of Infectious Diseases|August 1, 1993
DNA amplification in experimental pneumocystosis: characterization of serum Pneumocystis carinii DNA and potential P. carinii carrier statesK Sepkowitz, N Schluger, T Godwin, et al.Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complicationsH Vlassara, H Fuh, Z Makita, et al.Molecular Medicine (Cambridge, Mass.)|January 4, 1998
Molecular characterization of a mouse genomic element mobilized by advanced glycation endproduct modified-DNA (AGE-DNA)T Pushkarsky, L Rourke, L A Spiegel, et al.Molecular Medicine (Cambridge, Mass.)|June 20, 2000
Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivoM Takeuchi, Z Makita, R Bucala, et al.Pageof 19